Skip to content

SPAC Feed

Curated SPACs News

  • News
  • Opinions
  • Events
  • Videos
  • Resources
  • Contact Us
  • News
 Posted on October 20, 2026

TriGemX plans $246 million SPAC deal to fund migraine program – The Pharma Letter

TriGemX plans $246 million SPAC deal to fund migraine program  The Pharma Letter
By sf-admin

Post navigation

Houston-based SPAC taking battery startup Sakuu public after previous deal canceled – The Business Journals
16 deals show space SPACs have a poor record for investors – SpaceQ


  • About Us
  • Contact Us
  • Subscribe
Copyright © 2026 SPAC Feed. All Rights Reserved | News Vibe by Theme Palace